MÉDIPRÉMA

NEONATOLOGY

Founded in 1976, Médipréma has established itself as one of Europe’s leading players in neonatology. Its products are organised around two complementary brands:

• Beldico: single-use feeding consumables for neonatal units (feeding bottles, teats, nipple shields, feeding caps)
• Médipréma: design, manufacturing and distribution of neonatal medical equipment (incubators, phototherapy and transport equipment)

With more than 200 employees across two sites, in France (Tauxigny, Centre-Val de Loire) and in Belgium, Médipréma markets its solutions in more than 50 countries.

KEY STRENGTHS

High barriers to entry: regulatory (MDR certification, sterility), technical (R&D, co-development with university hospitals) and reputational (well-known brand, long-standing listings). The cost of MDR compliance, already achieved across the entire range, is a strong deterrent for comparable competitors.

The only independent European player covering all the needs of neonatal units, with a 60 to 70% market share in consumables in France and Belgium (exclusive supplier to AP-HP, holder of the UNIHA contract), in a critical and low-cyclicality segment.

RESPONSIBLE APPROACH

The group follows a structured CSR approach, backed by ISO 14001 certification for environmental management. It promotes the circular economy through the recycling and recovery initiatives carried out by Médipréma and the use of recycled cardboard by Beldico.

Quality is also a key pillar of its strategy, with ISO 13485 certification.

PROJECT

Innovafonds invested in the group in 2025 through a majority LBO.

Innovafonds supports the group’s growth strategy along three main pillars:

• ORGANIC GROWTH: international expansion (Africa, Middle East, ...)

• OPERATIONAL STRENGTHENING: recruitment of a new Chairman & CEO and two sales directors

• EXTERNAL GROWTH: several targets identified in France, Switzerland, Italy, Germany and the United Kingdom